[Pharmacokinetics, metabolism and mechanism of action of a new anti-obesity drug (11698 J.L.) (author's transl)].
D000328:Adult; D000818:Animals; D001067:Appetite Depressants / Q000378:metabolism* / Q000494:pharmacology; D002478:Cells, Cultured; D004285:Dogs; D005260:Female; D006801:Humans; D007189:Indans / Q000378:metabolism* / Q000494:pharmacology; D007192:Indenes / Q000378:metabolism*; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D008297:Male; D051381:Rats; D013045:Species Specificity
D001067:Appetite Depressants; D007189:Indans; D007192:Indenes; D007328:Insulin
Etude de la pharmacocinétique, du métabolisme et du mécanisme d'action du 11698 J.L., chlorhydrate d'(amino-1 propyl) 2 indanol-2, nouveau médicament pour le traitement de l'obésité.